Vaxart, Inc. announced a change in management. Effective immediately Andrei Floroiu, President and Chief Executive Officer of Vaxart, has announced his resignation from his positions with Vaxart as Chief Executive Officer. Michael J. Finney, Ph.D., the Chair of Vaxart?s Board of Directors, has assumed the role of Interim Chief Executive Officer to lead the management team through this transition.

Vaxart is conducting a CEO search for Mr. Floroiu?s successor. Dr. Finney has served as a member of the Board of Directors since February 2018 and Chair of the Board of Directors since March 2023. He will continue on the Board of Directors while serving as Interim Chief Executive Officer.